Delivery Order SPE2DR25D3005-SPE2DR26FP8MV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Concerta ER 18 mg tablets (100-count packages) valued at $15,452.62, with completion targeted for January 12, 2026. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $34.3K delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Concerta ER 18 mg tablets (100-count units). This competitively awarded, firm fixed-price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1B and extending through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Concerta ER 54 mg tablets (100-count units) valued at $1,199.34, with a firm fixed price arrangement. The contract was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,691.96 to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100 count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price, non-set-aside contract was awarded competitively and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order represents a task order issued under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (subsidiary of parent company Cencora, Inc.) on January 12, 2026, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $1,109.62. This is a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, with performance to be completed at the company's Conshohocken, Pennsylvania location. The award was made on a non-set-aside, competitive basis and...
- The Defense Logistics Agency awarded a delivery order valued at $1,878.13 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg on January 6, 2026, with completion scheduled for January 7, 2026. The award was competitively procured with no set-aside designation and utilizes firm fixed-price pricing. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the operating subsidiary of parent company Cencora, Inc., a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,969.28 for Concerta ER 18 mg tablets (100 count) on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed price contract, which carries no set-aside designation, was competitively awarded and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,948.54 on July 14, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 15, 2025. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor...
- The Defense Logistics Agency awarded a $1,580.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This contract, with an ultimate completion date of October 20, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The order will be fulfilled from...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Concerta ER Tablets 18mg, with a ceiling value of $1,588.38. This is a firm fixed-price delivery order with no set-aside designation, completed competitively. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. This delivery order is issued under...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8MVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,273.54 to AmerisourceBergen Drug Corp for the supply of Concerta ER 18 mg tablets (100-count) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and specialized healthcare commodities. The DLA Troop Support Medical IDC enables efficient delivery of essential pharmaceutical products to military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. This particular delivery order for Concerta ER—a controlled-release methylphenidate medication used for attention deficit hyperactivity disorder treatment—exemplifies the company's ongoing role in supplying prescription medications across multiple therapeutic domains to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 1/11/26 |